[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Crinetics Pharmaceuticals, Inc.
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +17%
6 Months: XXX% +38%
1 Year: XXX% no change
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-05-07
Most Supportive Themes
- Positive Analyst Ratings and Biotech Momentum: (35%) Posts highlight positive analyst ratings and the strong performance of biotech stocks, including CRNX.
- FDA Approval and Product Launch: (25%) News of FDA approval for Palsonify, Crinetics' first approved product, is generating positive sentiment.
- Stock Performance and Technical Analysis: (20%) Posts discuss CRNX's strong performance, with mentions of significant gains and positive trends.
Most Critical Themes
- Competition and Market Challenges: (5%) Mentions of competition from established drugs suggest potential challenges for CRNX.
- General Market Volatility: (5%) Some posts mention market volatility and the broader economic context, which could impact CRNX.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXXXX | XX% | XX | X% |
| Total | XXX | XX% | XXXXX | XX% | XX | X% |